New York, United States, 31st January, 2023, Chainwire
BNB Chain decentralized exchange Biswap has published its 2023 roadmap which includes a number of proposed improvements and upgrades. It includes details of a new AMM, route optimization, and perpetual trading.
Take a look at the main Biswap benefits: https://biswap.org/.
A new AMM protocol with concentrated liquidity will allow Liquidity Providers to accumulate their capital to smaller price intervals than from 0 to infinity, increasing capital use efficiency and providing users with more profitable exchange conditions with less slippage.
Improved routing to find the best trading pairs will allow users to execute larger transactions with less slippage and increase capital efficiency, as well as receive greater rewards from trading fees for Liquidity Providers.
To reduce pressure on the price of the native Biswap token and provide opportunities for more earnings for long-term BSW token holders, the Biswap team has developed several initiatives. In the future, they will be explained and put forward to BSW holders for voting.
Evolving market trends have also prompted the Biswap team to implement decentralized futures trading (with an on-chain order book on the BNB network). To implement this idea in a safe manner, the team has decided to connect a ready-made solution from ApolloX at this stage of product development.
As part of the Biswap ecosystem expansion, there are plans to create a widget that will increase trading with Biswap Liquidity and make it more convenient for users to exchange tokens. This will be available for implementation on third-party products.
Biswap’s progressive DEX on BNB Chain features a Multi-type Referral Program and low trading fees of 0.1%. The platform provides various services with cryptocurrencies, such as Exchange, Farming, and Staking. Moreover, the project has its native BEP-20 token, BSW, which allows users to join the most popular features on the platform. The primary BSW function is to incentivize liquidity provision to the Biswap platform.
High LP rewards allow Liquidity Providers to get 0.15% back from token swap transactions. Also, Liquidity Providers can stake LP tokens on farms to earn BSW tokens with competitive APYs. Up to 50% trade fee reimbursement returns users the transaction fee when they exchange tokens. The system automatically gives back the fee in the form of BSW tokens. Explore Biswap NOW
About Biswap
Biswap is the progressive DEX platform on the BNB Chain network with a Multi-type Referral Program and the lowest trade fee of 0.1%. The platform provides various services with cryptocurrencies, such as Exchange, Farming, Staking and others.
Contact
Marketing Biswap
Biswap
[email protected]
When I was MUCH younger, say 30 years back (!!!), I subscribed to the AAAS “Science” weekly magazine. You may have seen it … dense, very technical, primary research articles from just about anyone at the front edge of research. Mostly I was interested in the physics, chemistry and digital research bits. But I was awed by the mass of biological, biochemical and genetics related articles too.
What I found most annoying was that in each domain, but especially in the emerging sciences areas, the lingo was dense, highly acronym-laced and also full of English-sounding words that clearly were borrowed and yet totally changed so as to no longer mean what one might naively believe they meant. Very annoying.
This article summary, above, is just such an annoying salad of cut up words and acronyms. I’ve read it carefully a couple of times, and to be frank I have almost no idea what the jargon is trying to inform.
What, say, is an AMM (transaction?) The acronym is not helpfully decoded. What is a liquidity partner, exactly? What is capital use efficiency defined as? What does it even mean to accumulate capital in a SMALLER interval than zero-to-infinity? Zero seems to be the smallest interval. If … I can still digest English. And most important, since the word is used a bunch, what the heck is ‘slippage’?
Almost exactly my reaction when I read a dense article of some genetic research paper, filled to the gills with jargon. Oh, heck, with a lot of Googling, I can eventually ‘suss out what many (but not all!) of the terms mean. But by the time I’ve done that, I find I’m no longer even terribly interested in the article’s breathless proclamations. Word salad.
Please dear Brian … please try to digest some of these jargonista’s press releases into something more informative. Thanks…
GoatGuy